---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291951435.md"
description: "Dyadic International shares are trading higher after the company announced continued progress across multiple global health collaborations validating its proprietary C1 protein production platform potential."
datetime: "2026-07-07T14:39:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291951435.md)
  - [en](https://longbridge.com/en/news/291951435.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291951435.md)
generator: "portal-rs"
---

# 

Dyadic International shares are trading higher after the company announced continued progress across multiple global health collaborations validating its proprietary C1 protein production platform potential.

### Related Stocks

- [DYAI.US](https://longbridge.com/en/quote/DYAI.US.md)

## Related News & Research

- [Dyadic International Announces New Equity Financing Agreements](https://longbridge.com/en/news/295944873.md)
- [Dyadic International prices unregistered warrant private placement at $0.005 per warrant](https://longbridge.com/en/news/295795006.md)
- [Gentian Diagnostics hosts webinar on circulating calprotectin use in rheumatic disease management](https://longbridge.com/en/news/296439040.md)
- [11:39 ETJiMMYBAR! Expands into Sam's Club with Nationwide Online Availability and California Club Rollout](https://longbridge.com/en/news/296377299.md)
- [Volare opens commercial-scale insect protein plant in Pori with EUR 15 million investment](https://longbridge.com/en/news/296203318.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**